Vanguard discloses stakes of 4.80% in Tate & Lyle and 3.58% in Spire Healthcare
The Vanguard Group reported holding 4.80% of Tate & Lyle and 3.58% of Spire Healthcare as of October 26, 2026, according to EQS News.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to EQS News, The Vanguard Group, Inc. disclosed on October 27, 2026 its positions in shares of two UK companies that are subject to takeover rules. As of October 26, the fund held 21,367,217 ordinary shares in Tate & Lyle plc, equal to 4.80% of the capital, after buying 3,627 shares at 5.64 GBP. In Spire Healthcare Group plc, it holds 14,409,868 shares, or 3.58%, following a purchase of 2,574 shares at 2.48 GBP.
why it matters
Such filings are required when an investor's holding in a company that may be subject to an offer exceeds 1%. The small purchases are minor relative to the total share counts of both companies, but they show a large institutional investor continuing to build exposure to both stocks.
tags
instruments
sources
- Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc — eqs-news.com, 27 October 2026 at 13:08 UTC
- Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc — eqs-news.com, 27 October 2026 at 13:08 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗